Skip to content

CASE STUDIES

PharmaKB data has many applications. Read these case studies to learn how the knowledgebase can help you. For specific use cases, see our Solutions page.


biometadata-icon-1

Financial Analysis of Competitive Drugs

A case study using PharmaKB to compare competing commercial drugs. Financial investors and pharmaceutical industry leaders utilize the information in PharmaKB to make superior investment and product development decisions...

Read More

 

 

biometadata-icon-1

Method for Trend Based Forecasting of Drug Revenues

A case study using PharmaKB to predict company revenues from key indicators of research and market performance…

Read More

 

 

biometadata-icon-1

Patent Cliff Analysis Support for Generic Drug Decisions

Patent termination events have a startling effect on company revenue. This case study shows FDA reported patent terminations for Rheumatoid Arthritis drugs and summarizes the timing of opportunities for generics companies to enter the market.…

Read More

 

 

biometadata-icon-1

Reagent Array Drug Sample Selection and Acquisition Program Uses PharmaKB Content

PharmaKB content may be used within 3rd party commercial applications. In this case, Reagent Array, a specialty screening sample provider, enables drug sample selection based on key properties from the PharmaKB database.

Read More

 

 

biometadata-icon-1

Tracking Trends and Revenue (Cancer Drugs)

A case study using PharmaKB data to explore trending cancer therapies for multiple myeloma and their impact on revenues of existing treatment regimens. Overall, this case study demonstrates how PharmaKB can be used to investigate changes to the treatment landscape for a particular disease…

Read More

 

 

biometadata-icon-1

Combination Therapies for COVID-19 and Implications for Drug Safety

Combination Therapies for COVID-19 and Implications for Drug Safety using PharmaKB to identify combination therapies in clinical trials for COVID-19. PharmaKB collects and collates a broad range of drug information, allowing users to…

Read More